Tickr
Home Explore Daily Brief Market Watchlists Portfolio
Research
Catalysts Signal Factory Screener Market News Event Calendar Valuation Plot Heat Map Top Investors Industry Trends Options
AI Assistant Notifications Account
Scinai Immunotherapeutics Ltd. logo

Scinai Immunotherapeutics Ltd. (SCNI) Stock Ticker

NASDAQ: SCNI · Healthcare · Biotechnology
$1.55-16.67%
USD · as of 2026-09-27 · market cap $801,254
Open SCNI in TickrDownload for iPhone

SCNI right now

Down 36% in the last month.
From Tickr's live models · 2026-09-29. Not investment advice.

Market factors today

Tickr 500 vs S&P 500+0.49%+1.0% MTD
Momentum L/S+1.35%+15.1% MTD
High-beta momo L/S+1.46%+22.2% MTD
Rate sensitivity L/S+1.91%+6.9% MTD
Oil sensitivity L/S-2.54%-5.3% MTD
Unprofitable tech-1.43%+3.7% MTD

Unlock the full SCNI picture

🔒 Implied move chart & probabilities
🔒 Live options flow
🔒 AI analysis & chat on SCNI
🔒 Catalysts & earnings
🔒 Strategy Lab
🔒 Financials & estimates
Start your 7-day free trial

About Scinai Immunotherapeutics Ltd.

Scinai Immunotherapeutics Ltd. operates as an emerging biopharmaceutical company, dedicated to the research, production, and market introduction of medical solutions. Based in Israel, its primary objective is the prevention and treatment of a range of infectious, autoimmune, and other health conditions. The company maintains a significant licensing and collaboration agreement with the Max Planck Society and the University Medical Center Göttingen. This partnership is focused on advancing and commercializing a nanosized antibody (NanoAb) specifically for COVID-19, in addition to pursuing NanoAb applications for various other disease indications. Established in 2003, the company was formerly known as BiondVax Pharmaceuticals Ltd. before rebranding to Scinai Immunotherapeutics Ltd. in September 2023. Its corporate headquarters are situated in Jerusalem, Israel.

SCNI stock facts

Ticker symbolSCNI
ExchangeNASDAQ Capital Market
SectorHealthcare
IndustryBiotechnology
Market cap$801,254
CEOAmir Reichman
Employees45
HeadquartersJerusalem, JM, IL
IPO date2015-05-11
Websitewww.scinai.com

What you can see for SCNI on Tickr

Live SCNI price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the SCNI report.

Rankings

Largest Healthcare companiesLargest companies by market cap

FAQ

What is the ticker symbol for Scinai Immunotherapeutics Ltd.?

The ticker symbol for Scinai Immunotherapeutics Ltd. is SCNI, listed on the NASDAQ Capital Market.

What is SCNI?

Scinai Immunotherapeutics Ltd. operates as an emerging biopharmaceutical company, dedicated to the research, production, and market introduction of medical solutions. Based in Israel, its primary objective is the prevention and treatment of a range of infectious, autoimmune, and other health conditions. The company maintains a significant licensing and collaboration agreement with the Max Planck…

HomeExploreMarketLists
All pages